BIOMAT Database Logo BIOMAT Database Logo

Episode sequence in bipolar disorder and response to lithium treatment. 1991

G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Department of Psychiatry, Harvard Medical School, Boston.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D016001 Confidence Intervals A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable. Confidence Interval,Interval, Confidence,Intervals, Confidence
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios

Related Publications

G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Stargazin involvement with bipolar disorder and response to lithium treatment.
May 2008, Pharmacogenetics and genomics,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Response to lithium in bipolar disorder: clinical and genetic findings.
June 2014, ACS chemical neuroscience,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Variant GADL1 and response to lithium in bipolar I disorder.
May 2014, The New England journal of medicine,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Variant GADL1 and response to lithium in bipolar I disorder.
May 2014, The New England journal of medicine,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Variant GADL1 and response to lithium in bipolar I disorder.
May 2014, The New England journal of medicine,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Variant GADL1 and response to lithium in bipolar I disorder.
May 2014, The New England journal of medicine,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Variant GADL1 and response to lithium in bipolar I disorder.
May 2014, The New England journal of medicine,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Variant GADL1 and response to lithium in bipolar I disorder.
May 2014, The New England journal of medicine,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Lithium treatment for bipolar disorder.
January 2000, Bulletin of the World Health Organization,
G L Faedda, and R J Baldessarini, and M Tohen, and S M Strakowski, and C Waternaux
Episode frequency prior to lithium treatment in bipolar manic-depressive patients.
January 1979, Comprehensive psychiatry,
Copied contents to your clipboard!